Parvovirus B19 infection in AIDS patients

International Journal of STD and AIDS

Volumn 8, Issue 3, 1997, Pages 184-186

  Kerr, J R ^a   Kane, D ^b   Crowley, B ^c   Leonard, N ^c   O'Briain, S ^c   Coyle, P V ^d   Mulcahy, F ^c  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c ST JAMES S HOSPITAL   (Ireland)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

AIDS; parvovirus B19

Indexed keywords

HEMOGLOBIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BONE MARROW; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; BONE MARROW; DNA, VIRAL; FEMALE; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 0030888760     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462971919688     Document Type: Article

References (23)

1. Kerr JR, Parvovirus B19 infection. Eur J Clin Microbiol Infect Dis 1996;15:10-29
2. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blease RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989;84:1114-23
3. Frickhofen N, Abkowitz JL, Safford M, et al. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type-1 (HIV-1); a treatable cause of anaemia in AIDS. Ann Intern Med 1990;113:926-33
4. de Mayolo JA, Temple JD. Pure red cell aplasia due to parvovirus B19 infection in a man with HIV infection. South Med J 1990;83:1480-1
5. Mitchell SA, Welch JM, Weston-Smith S, Nicholson F, Bradbeer CS. Parvovirus infection and anaemia in a patient with AIDS: case report. Genitourin Med 1990;66:95-6
6. Bowman CA, Cohen BJ, Norfolk DR, Lacey CJ. Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous immunoglobulin. AIDS 1990;4:1038-9
7. Gottlieb F, Deutsch J. Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection. Am J Med 1992;92:331-3
8. Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT. Parvovirus B19 infection in human immunodeficiency virus type-1 infected persons failing or intolerant to zidovudine therapy. J Infect Dis 1993;168:101-5
9. Kurtzman GJ, Frickhofen NK, Kimball J, Jenkins DW, Niehuis AW, Young NS. Pure red cell aplasia of 10 years duration due to persistent parvovirus infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-23
10. Azzi A, Macchia PA, Favre C, Nardi M, Zakrzewska K, Corsi OB. Aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukaemia. Haematologica 1989;74:191-4
11. Neild G, Anderson M, Hawes S, Colvin BT. Parvovirus infection after renal transplant. Lancet 1986;2:1226-7
12. Niitsu H, Takatsu H, Miura I, et al. Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation (Japanese). Rinsho Ketsueki 1990;31:1566-71
13. Graeve JL, de Alarcon PA, Naides SJ. Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol 1989;11:441-4
14. Chomoczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993;15:532-6
15. Kerr JR, Curran MD, Moore JE, et al. Genetic diversity in the non-structural gene of parvovirus B19 detected by single-stranded conformational polymorphism assay (SSCP) and partial nucleotide sequencing. J Virol Meth 1995;53:213-22
16. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR. Nucleotide sequence and genome organisation of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36
17. Anderson MJ, Kidd IM, Jones SE, et al. Parvovirus infection and the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:275
18. Abkowitz JL, Brown KE, Wood RW, Cohen BJ, Kovach NL, Yound NS. Human parvovirus B19 (HPV B19) is not a rare cause of anaemia in HIV-seropositive individuals. Clin Res 1993;41:393
19. Kerr JR, Curran MD, Moore JE, Coyle PV, Ferguson WP. Persistent parvovirus B19 infection. Lancet 1995;345:1118
20. Ozawa K, Kurtzman G, Young N. Productive infection by B19 parvovirus of human erythroid bone marrow in vitro. Blood 1987;70:384-91
21. Brown KE, Mori J, Cohen BJ, Field AM. In vitro propagation of parvovirus B19 in primary fetal liver culture. J Gen Virol 1991;72:741-5
22. Young N, Harrison M, Moore J, Mortimer PP, Humphries RK. Direct demonstration of the human parvovirus in erythroid progenitor cells infected in vitro. J Clin Invest 1984;74:2024-32
23. Van Horn DK, Mortimer PP, Young N, Hanson GR. Human parvovirus-associated red cell aplasia in the absence of underlying haemolytic anaemia. Am J Pediatr Hematol Oncol 1986;8:235-9